Policy & Advocacy   |   Policy Summit

Next Week: Connect, Collaborate, and Innovate at the 2024 Policy Summit

Register to join us Sept. 23-24! - September 17, 2024

This 1.5 day event offers an unparalleled opportunity to engage in high-level discussions with expert presenters, gain actionable insights, and contribute to shaping the policies that will drive the future of our field.

You know that cell and gene therapies are revolutionizing treatment paradigms - and that understanding the evolving policy landscape has never been more crucial. Regulatory practices, investment trends, and patient access challenges can change the course of your development strategy. This 1.5-day event offers an unparalleled opportunity to engage in high-level discussions with expert presenters, gain actionable insights, and contribute to shaping the policies that will drive the future of our field.

Whether you're a seasoned expert or new to the policy side of CGT, the Policy Summit promises to equip you with the knowledge and connections needed to navigate the complex interplay of science, policy, and patient care. View the full agenda below and join us next week! ASGCT members save $200—register now!

Register          Agenda

Day 1 - September 23

Global Regulatory Landscape 101

  • Case study from Intellia Therapeutics on navigating international regulatory submissions

Global Regulatory Convergence

  • Featuring speakers from FDA CBER, Spanish Agency of Medicines and Medical Devices, Japanese Pharmaceutical & Medical Devices Agency, and Health Canada

The Investment Landscape for CGTs

  • Speakers from Deerfield Management, RA Capital, Sanofi Ventures, and ARPA-H

Fireside Chat: Administration Payment Policy

  • Discussion on CMMI's CGT Access Model and federal efforts on outcomes-based arrangements

Translational Science: Driving Therapies Forward

  • Fireside chat with Joni Rutter, PhD, Director of NCATS

Bridging Perspectives: Insights from Former FDA Leaders

  • Featuring Wilson Bryan, MD and Kim Benton, PhD

2025 Payment Policy Look-Ahead

  • Forward-looking discussion on value-based arrangements, coverage and reimbursement challenges, and how the political landscape could broadly impact payment policy

Networking Opportunity

  • Join us for an on-site networking reception to connect with peers and thought leaders in the field
 

Day 2 - September 24

Fireside Chat: Food & Drug Administration Policy

  • Featuring Julie Tierney, JD, FDA CBER

Hot Topics in Clinical Development: Risk-benefit Analysis

  • Panelists from FDA CBER, Mammoth Biosciences, Forge Biologics, and Kite Pharma

CGTs in the States: Medicaid Coverage

  • Discussion with current and former Medicaid directors on state-level considerations for CGT coverage

Register          Agenda

Related Articles

Policy & Advocacy

Congressional Briefing Highlights CGT Research for HIV

Paula Cannon, PhD - December 18, 2024
Policy & Advocacy

Advancing CGTs in 2024: ASGCT’s Policy and Advocacy Highlights

Caitlin McCombs, MBA - December 18, 2024
Policy & Advocacy

Navigating Challenges in AAV Gene Therapy: A Preview of the FDA-Partnered Workshop

Andrew Liermann - December 03, 2024
Policy & Advocacy

ASGCT-AAAS Congressional Policy Fellow Reflects on First Weeks

Adriana Bankston, PhD - November 19, 2024